Ten Years of Change in Bariatric/Metabolic Surgery in the Asia–Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021 - Takeaways - MDSpire

Ten Years of Change in Bariatric/Metabolic Surgery in the Asia–Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021

  • By

  • Masayuki Ohta

  • Soo Min Ahn

  • Yosuke Seki

  • Wah Yang

  • Simon Kin-Hung Wong

  • Suthep Udomsawaengsup

  • Jeffrey M. Hamdorf

  • Manish Khaitan

  • Nik Ritza Kosai

  • Weu Wang

  • June Lee

  • Reno Rudiman

  • Thejana Wijeratne

  • Edward Oliveros

  • Cunchuan Wang

  • Kazunori Kasama

  • June 30, 2022

  • 0 min

Share

  • 1

    The IFSO-APC was founded in 2008, promoting bariatric and metabolic surgery across the Asia-Pacific region.

  • 2

    Bariatric surgery indications in Asian candidates include a BMI ≥ 35 kg/m2, while metabolic surgery is indicated for BMI ≥ 30 kg/m2 with T2DM.

  • 3

    The number of patients undergoing bariatric/metabolic surgery in the Asia-Pacific region increased from 28,773 in 2013 to 70,573 in 2018.

  • 4

    A virtual meeting in 2021 presented a decade of changes in bariatric/metabolic surgery and the impact of COVID-19 on these practices.

  • 5

    Data on obesity and T2DM prevalence, surgical indications, and healthcare coverage were collected from 14 national societies for analysis.

Original Source(s)

Ten Years of Change in Bariatric/Metabolic Surgery in the Asia–Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021

  • by Masayuki Ohta, Soo Min Ahn, Yosuke Seki, Wah Yang, Simon Kin-Hung Wong, Suthep Udomsawaengsup, Jeffrey M. Hamdorf, Manish Khaitan, Nik Ritza Kosai, Weu Wang, June Lee, Reno Rudiman, Thejana Wijeratne, Edward Oliveros, Cunchuan Wang, Kazunori Kasama

  • June 30, 2022

Related Content

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Uterine-Sparing vNOTES vs. laparoscopic lateral suspension for pelvic organ prolapse repair: a prospective comparative study of feasibility and early outcomes